-
genomic and immunological assays to identify drivers of disease (such as lupus or cancer) and then utilize immune engineering and synthetic biology to identify novel treatments. Our lab has been recently
-
Johan Paulsson’s lab at Harvard Medical School is spearheading a nationwide initiative to combat antimicrobial resistance using high-precision technology that requires novel microfluidics and
-
The Rowland Institute at Harvard seeks outstanding early-career experimentalists in all fields of science and engineering to establish fully independent research groups in the rich intellectual
-
— problems in the field. You’ll have opportunities to: Collaborate with and learn from with highly specialized experts Train on and use world-class technology Conduct research at the NIH Clinical Center
-
-world impact in natural sciences and engineering-related disciplines. Our program intends to support research that is driven by the fellow and enables them to pursue their own creative ideas in
-
or vaccination outcomes to identify an immunological signature associated with protective viral immunity. Responsibilities: Lead a project on developing a novel AI platform engineered and utilized the platform
-
. We utilize a multifaceted approach that encompasses preclinical studies in immune competent syngeneic and genetically engineered co-mutational models of KRAS - mutant NSCLC as well as PDX/CDXs, in
-
or vaccination outcomes to identify an immunological signature associated with protective viral immunity. Responsibilities: Lead a project on developing a novel AI platform engineered and utilized the platform